Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.86)
# 65
Out of 5,090 analysts
25
Total ratings
82.35%
Success rate
59.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Equal-Weight | $17 → $25 | $26.69 | -6.33% | 3 | Nov 19, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Equal-Weight | $8 → $11 | $18.20 | -39.56% | 3 | Nov 11, 2025 | |
| RLAY Relay Therapeutics | Maintains: Equal-Weight | $4 → $6 | $7.68 | -21.88% | 1 | Nov 7, 2025 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $60 | $38.78 | +54.72% | 1 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Overweight | $25 → $29 | $25.45 | +13.95% | 4 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Equal-Weight | $95 → $97 | $96.14 | +0.89% | 5 | Sep 30, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $42 → $45 | $41.67 | +7.99% | 3 | Sep 25, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $67 → $70 | $79.64 | -12.10% | 1 | Sep 11, 2025 | |
| XNCR Xencor | Maintains: Overweight | $33 → $27 | $17.30 | +56.07% | 3 | Aug 7, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $44 | $35.87 | +22.67% | 1 | Jun 26, 2025 |
Zymeworks
Nov 19, 2025
Maintains: Equal-Weight
Price Target: $17 → $25
Current: $26.69
Upside: -6.33%
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $18.20
Upside: -39.56%
Relay Therapeutics
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $4 → $6
Current: $7.68
Upside: -21.88%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $38.78
Upside: +54.72%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25 → $29
Current: $25.45
Upside: +13.95%
Merus
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $95 → $97
Current: $96.14
Upside: +0.89%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42 → $45
Current: $41.67
Upside: +7.99%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67 → $70
Current: $79.64
Upside: -12.10%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33 → $27
Current: $17.30
Upside: +56.07%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $35.87
Upside: +22.67%